Results 201 to 210 of about 140,945 (289)

Highly Efficient Sky‐Blue Perovskite Quantum Dot Light‐Emitting Diodes via Ligand‐Assisted Trap‐State Passivation

ENERGY &ENVIRONMENTAL MATERIALS, EarlyView.
Highly efficient sky‐blue LED with EQE of 13.6% is realized through short‐chain ligand tridecylamine treaded perovskite quantum dots, due to the suppressed non‐radiative recombination from the trap state. These results indicate that the ligand with strong affinity can facilitate the surface defects passivation, resulting in enhanced optical properties,
Mengyu Zhu, Wei Gao, Qi Wei, Lyuchao Zhuang, Zhiwen Cheng, Mengjuan Sun, Chao Xu, Rui Zhi, Junyi Chen, Jingshan Hou, Ye Zhu, Jun Yin, Mingjie Li, Siu Fung Yu, Yongzheng Fang   +14 more
wiley   +1 more source

Effects of Roystonea Regia (D-004) and Saw Palmetto Lipid Extracts in Men with Symptomatic benign Prostatic Hyperplasia

IOSR Journal of Pharmacy (IOSRPHR), 2013
openaire   +1 more source

PVN-LOT-169-D-004 [PDF]

, 1988
Neff, Theodore
core   +8 more sources

Enhanced Nonlinear Optical Absorption Properties and Carrier Dynamics of Violet Phosphorene by Oxidation for Ultrafast Photonic Applications

ENERGY &ENVIRONMENTAL MATERIALS, EarlyView.
This study investigates the effects of oxidation treatment on the nonlinear optical absorption properties and carrier dynamics of two‐dimensional violet phosphorene (VP), elucidating the underlying physical mechanisms. Furthermore, ultrashort laser pulses are achieved utilizing the enhanced saturation absorption and shortened carrier relaxation ...
Bo Li, Han Pan, Qingling Tang, Zhongben Pan, Hongwei Chu, Ying Li, Dechun Li   +6 more
wiley   +1 more source

Efficacy and Safety of 5-Aminolevulinic Acid Hydrochloride Combined with Sodium Ferrous Citrate in Pediatric Patients with Leigh Syndrome and Central Nervous System Disorders: An Initial Exploratory Trial with a Double-Blind Placebo-Controlled Period, Followed by an Open-Label Period and a Subsequent Long-Term Administration Study. [PDF]

Life (Basel)
Abe Y, Hamasaki T, Natsume J, Mogami Y, Murayama K, Shiraishi H, Abe Y, Kumada S, Tanaka R, Ihara K, Sakakibara T, Okazaki Y, Nakagawa H, Takahashi K, Yamauchi M, Nakajima M, Ohtake A.   +16 more
europepmc   +1 more source

N‐terminal pro‐brain natriuretic peptide and cardiorenal outcome in patients with anaemia in chronic kidney disease

ESC Heart Failure, Volume 12, Issue 2, Page 848-858, April 2025.
Abstract Aims Blood levels of N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) may be modified by low renal clearance and anaemia. The aim of this study was to investigate the impact of the blood NT‐proBNP level on cardiovascular and renal outcomes in patients with these two manifestations.
Hiroshi Nishi, Masaomi Nangaku, Tadashi Sofue, Tatsuo Kagimura, Ichiei Narita   +4 more
wiley   +1 more source

Biomechanical and neuromuscular differences between professional and varsity football players during countermovement and approach jumps. [PDF]

PLoS One
Garcia G, Bucheli R, Castillo JT, Fernandez J, de la Torre A, Fierro AL, Montiel W, Arauz PG.   +7 more
europepmc   +1 more source

PVN-LOT-019-D-004 [PDF]

, 1988
Kane, Sonya
core   +1 more source

Exploring the role of apolipoprotein ε4 in progressive myoclonic epilepsy type 1

Epileptic Disorders, EarlyView.
Abstract Objective Progressive myoclonic epilepsy type 1 (EPM1) is a neurodegenerative disease caused by biallelic variants in the cystatin B (CSTB) gene. Despite a progressive course, phenotype severity varies among patients, even within families. We studied the potential role of APOE ε4 in modifying phenotypic diversity in EPM1, given its established
Janina Gunnar, Yawu Liu, Henri Eronen, Tarja Joensuu, Marja Äikiä, Jelena Hyppönen, Katri Silvennoinen, Esa Mervaala, Juhana Hakumäki, Anna‐Elina Lehesjoki, Reetta Kälviäinen   +10 more
wiley   +1 more source

A Re-Exploration of our Unconscious: What We Have Come To Unmask; What Still Lies Beneath. [PDF]

Integr Psychol Behav Sci
Tsikandilakis M, Bali P, Pasachidou VM, Toranzos RL, Szczesniak K, Mével PA, Madan C, Milbank A.   +7 more
europepmc   +1 more source